NATICK, Mass., Feb. 15, 2011 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced that it has established a $1.7 million endowment to fund the "Donald S. Baim, M.D., '75 Scholarship Fund" for Yale School of Medicine. This scholarship fund will honor the late interventional cardiology pioneer and Yale School of Medicine graduate who served as Boston Scientific's Chief Medical and Scientific Officer from 2006 until 2009, when he died unexpectedly.
At Boston Scientific, Dr. Baim provided oversight to preclinical and clinical studies, educational programs and physician relationships. He was a key contributor to the Company's technology development strategy, including the assessment of strategic acquisitions and partnering opportunities, while also serving as the Company's leading patient advocate for new products and procedures. Under Dr. Baim's leadership, Boston Scientific's Clinical Sciences group was strengthened considerably, increasing its emphasis on leading clinical research to support evidence-based medicine.
"Dr. Baim was a pioneer in interventional cardiology and less-invasive medicine who demonstrated remarkable intellect and passion across a range of disciplines," said Ray Elliott, President and Chief Executive Officer of Boston Scientific. "We are proud to honor his memory by supporting the next generation of medical leaders."
Dr. Baim enjoyed a prestigious career that included a position as Professor of Medicine at Harvard Medical School. He was a highly respected physician at Brigham and Women's Hospital and Beth Israel Hospital (now Beth Israel Deaconess Medical Center) in Boston, where he trained many of the interventional cardiology leaders of today. Dr. Baim was a prolific author, publishing nearly 300 scientific papers and editing a leading interventional cardiology textbook. He al